Market Cap (In CNY)
2.46 Billion
Revenue (In CNY)
953.98 Million
Net Income (In CNY)
80.87 Million
Avg. Volume
7.11 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7.49-14.33
- PE
- -
- EPS
- -
- Beta Value
- -0.136
- ISIN
- CNE100002QB5
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Da Lun Dong
- Employee Count
- -
- Website
- https://www.gyxtyy.com
- Ipo Date
- 2017-05-19
- Details
- Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of Chinese medicines for various diseases in China. The company offers formulation products, which include hard capsules, gels, mixtures, granules, and tablets. Its products are used for the treatment of antitumor, gynecological, urinary, breast thyroid, blood, heat, oral, anti-cold, and cardiovascular diseases. The company was founded in 1995 and is based in Guiyang, China.
More Stocks
-
PROXProximus PLC
PROX
-
SEAL-PASeapeak LLC
SEAL-PA
-
HTFC
-
002644
-
ALENOEnogia SAS
ALENO
-
PHGEBiomX Inc.
PHGE
-
VLVOFVolvo Car AB (publ.)
VLVOF
-
OSSIFOneSoft Solutions Inc.
OSSIF